Back to Search Start Over

CircTLK1 promotes the proliferation and metastasis of renal cell carcinoma by sponging miR-136-5p.

Authors :
Li, Jianfa
Huang, Chenchen
Zou, Yifan
Ye, Jing
Yu, Jing
Gui, Yaoting
Source :
Molecular Cancer. 6/5/2020, Vol. 19 Issue 1, p1-17. 17p. 8 Graphs.
Publication Year :
2020

Abstract

Background: Circular RNAs (circRNAs), a novel type of noncoding RNA (ncRNA), are covalently linked circular configurations that form via a loop structure. Accumulating evidence indicates that circRNAs are potential biomarkers and key regulators of tumor development and progression. However, the precise roles of circRNAs in renal cell carcinoma (RCC) remain unknown. Methods: Through circRNA high-throughput sequencing of RCC cell lines, we identified the circRNA TLK1 (circTLK1) as a novel candidate circRNA derived from the TLK1 gene. qRT-PCR detected the mRNA, circRNA and miRNA expression levels in RCC tissues and cells. Loss-of function experiments were executed to detect the biological roles of circTLK1 in the RCC cell phenotypes in vitro and in vivo. RNA-FISH, RNA pull-down, dual-luciferase reporter, western blot and immunohistochemistry assays were used to investigate the molecular mechanisms underlying the functions of circTLK1. Results: circTLK1 is overexpressed in RCC, and expression is positively correlated with distant metastasis and unfavorable prognosis. Silencing circTLK1 significantly inhibited RCC cell proliferation, migration and invasion in vitro and in vivo. circTLK1 was mainly distributed in the cytoplasm and positively regulated CBX4 expression by sponging miR-136-5p. Forced CBX4 expression reversed the circTLK1 suppression-induced phenotypic inhibition of RCC cells. Moreover, CBX4 expression was positively correlated with VEGFA expression in RCC tissues. CBX4 knockdown significantly inhibited VEGFA expression in RCC cells. Conclusion: Collectively, our findings demonstrate that circTLK1 plays a critical role in RCC progression by sponging miR-136-5p to increase CBX4 expression. circTLK1 may act as a diagnostic biomarker and therapeutic target for RCC. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14764598
Volume :
19
Issue :
1
Database :
Academic Search Index
Journal :
Molecular Cancer
Publication Type :
Academic Journal
Accession number :
143611874
Full Text :
https://doi.org/10.1186/s12943-020-01225-2